FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000147281> ?p ?o ?g. }

• W2000147281 endingPage "469" @default.
• W2000147281 startingPage "464" @default.
• W2000147281 abstract "Background Oral adjuvant chemotherapy without hospitalization might reduce the physiological and psychological burden on patients if effectiveness could be guaranteed. We conducted a multicenter feasibility study using S-1, an oral derivative of 5-fluorouracil, as postoperative adjuvant chemotherapy in patients with curatively resected pathologically stage IB-IIIA non–small-cell lung cancer. Patients and Methods Adjuvant chemotherapy comprised 8 courses (4-week administration, 2-week withdrawal) of S-1 at 80-120 mg per day. Fifty-one patients from 7 institutions were enrolled in this pilot study, from June 2005 to March 2007. The primary end point was the completion rate of scheduled adjuvant chemotherapy. Secondary end points were the incidence and grade of adverse reactions. Results Fifty patients were eligible. The completion rate for the planned 8 courses of S-1 administration was 72.0% (36 patients). Total percentage administration amount was 71.1%. Grade 3 adverse reactions such as neutropenia (4.0%), anorexia (4.0%), thrombopenia (2.0%), anemia (2.0%), elevated total bilirubin (2.0%), hypokalemia (2.0%), nausea (2.0%), and diarrhea (2.0%) were observed, but no grade 4 adverse effects were encountered. Overall and relapse-free survival rates at 3 years were 87.7% and 69.4%, respectively. Conclusions Postoperative 1-year administration of S-1 seems feasible as oral adjuvant chemotherapy for lung cancer. The oral formulation and low incidence of adverse reactions permit treatment on an outpatient basis. The present study would be reasonable to follow up with a properly powered phase III trial." @default.
• W2000147281 created "2016-06-24" @default.
• W2000147281 creator A5014748794 @default.
• W2000147281 creator A5032062009 @default.
• W2000147281 creator A5034151452 @default.
• W2000147281 creator A5036018761 @default.
• W2000147281 creator A5036714800 @default.
• W2000147281 creator A5053290611 @default.
• W2000147281 creator A5053773418 @default.
• W2000147281 creator A5072189264 @default.
• W2000147281 creator A5074006316 @default.
• W2000147281 creator A5081384276 @default.
• W2000147281 creator A5086697537 @default.
• W2000147281 creator A5091713925 @default.
• W2000147281 date "2012-11-01" @default.
• W2000147281 modified "2023-10-17" @default.
• W2000147281 title "A Multicenter Phase II Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non–Small-Cell Lung Cancer: High Completion and Survival Rates" @default.
• W2000147281 cites W1876410863 @default.
• W2000147281 cites W1972795497 @default.
• W2000147281 cites W2047722980 @default.
• W2000147281 cites W2053203412 @default.
• W2000147281 cites W2064792760 @default.
• W2000147281 cites W2075549113 @default.
• W2000147281 cites W2077902459 @default.
• W2000147281 cites W2089117117 @default.
• W2000147281 cites W2117994949 @default.
• W2000147281 cites W2127342594 @default.
• W2000147281 cites W2128395988 @default.
• W2000147281 cites W2137991416 @default.
• W2000147281 cites W2139730244 @default.
• W2000147281 cites W2170489771 @default.
• W2000147281 cites W310150161 @default.
• W2000147281 doi "https://doi.org/10.1016/j.cllc.2012.01.005" @default.
• W2000147281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22424872" @default.
• W2000147281 hasPublicationYear "2012" @default.
• W2000147281 type Work @default.
• W2000147281 sameAs 2000147281 @default.
• W2000147281 citedByCount "15" @default.
• W2000147281 countsByYear W20001472812013 @default.
• W2000147281 countsByYear W20001472812014 @default.
• W2000147281 countsByYear W20001472812015 @default.
• W2000147281 countsByYear W20001472812016 @default.
• W2000147281 countsByYear W20001472812017 @default.
• W2000147281 countsByYear W20001472812018 @default.
• W2000147281 countsByYear W20001472812020 @default.
• W2000147281 countsByYear W20001472812021 @default.
• W2000147281 crossrefType "journal-article" @default.
• W2000147281 hasAuthorship W2000147281A5014748794 @default.
• W2000147281 hasAuthorship W2000147281A5032062009 @default.
• W2000147281 hasAuthorship W2000147281A5034151452 @default.
• W2000147281 hasAuthorship W2000147281A5036018761 @default.
• W2000147281 hasAuthorship W2000147281A5036714800 @default.
• W2000147281 hasAuthorship W2000147281A5053290611 @default.
• W2000147281 hasAuthorship W2000147281A5053773418 @default.
• W2000147281 hasAuthorship W2000147281A5072189264 @default.
• W2000147281 hasAuthorship W2000147281A5074006316 @default.
• W2000147281 hasAuthorship W2000147281A5081384276 @default.
• W2000147281 hasAuthorship W2000147281A5086697537 @default.
• W2000147281 hasAuthorship W2000147281A5091713925 @default.
• W2000147281 hasBestOaLocation W20001472812 @default.
• W2000147281 hasConcept C126322002 @default.
• W2000147281 hasConcept C141071460 @default.
• W2000147281 hasConcept C197934379 @default.
• W2000147281 hasConcept C203092338 @default.
• W2000147281 hasConcept C2776256026 @default.
• W2000147281 hasConcept C2776694085 @default.
• W2000147281 hasConcept C2777063308 @default.
• W2000147281 hasConcept C2777299880 @default.
• W2000147281 hasConcept C2778239845 @default.
• W2000147281 hasConcept C2780580376 @default.
• W2000147281 hasConcept C2781451048 @default.
• W2000147281 hasConcept C535046627 @default.
• W2000147281 hasConcept C71924100 @default.
• W2000147281 hasConcept C90924648 @default.
• W2000147281 hasConceptScore W2000147281C126322002 @default.
• W2000147281 hasConceptScore W2000147281C141071460 @default.
• W2000147281 hasConceptScore W2000147281C197934379 @default.
• W2000147281 hasConceptScore W2000147281C203092338 @default.
• W2000147281 hasConceptScore W2000147281C2776256026 @default.
• W2000147281 hasConceptScore W2000147281C2776694085 @default.
• W2000147281 hasConceptScore W2000147281C2777063308 @default.
• W2000147281 hasConceptScore W2000147281C2777299880 @default.
• W2000147281 hasConceptScore W2000147281C2778239845 @default.
• W2000147281 hasConceptScore W2000147281C2780580376 @default.
• W2000147281 hasConceptScore W2000147281C2781451048 @default.
• W2000147281 hasConceptScore W2000147281C535046627 @default.
• W2000147281 hasConceptScore W2000147281C71924100 @default.
• W2000147281 hasConceptScore W2000147281C90924648 @default.
• W2000147281 hasIssue "6" @default.
• W2000147281 hasLocation W20001472811 @default.
• W2000147281 hasLocation W20001472812 @default.
• W2000147281 hasLocation W20001472813 @default.
• W2000147281 hasOpenAccess W2000147281 @default.
• W2000147281 hasPrimaryLocation W20001472811 @default.
• W2000147281 hasRelatedWork W1979960106 @default.
• W2000147281 hasRelatedWork W1991613108 @default.
• W2000147281 hasRelatedWork W2170402962 @default.
• W2000147281 hasRelatedWork W2348688227 @default.

• next